QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
BISCUITS – one of the largest Nordic RWE studies on osteoarthritis
Quantify’s Sara Hallberg, Emilie Toresson Grip & Anders Gustavsson are participating authors of one of the largest Nordic RWE studies on osteoarthritis (OA) conducted to date. The BISCUITS study includes all OA patients identified in specialist care in the Nordic countries, linking data on specialty and primary care, drug use, work absence, socioeconomics, pain severity and quality of life for patients and matched controls from the general population.
[…]
11 April is World Parkinson’s Disease Day
Parkinson’s is a progressive incurable brain disease estimated to affect more than 10 million people worldwide. The disease affects physical movement, but it also exacts a social toll. Sufferers drop activities, relinquish long-held roles to their spouses, and can suffer from depression.
In the Quantify research program on Parkinson´s disease we, amongst other things, analyze treatment patterns and the number of healthcare […]
Supplementation with nutritional vitamin D may be useful to prevent PTH levels from increasing
A meta-analysis conducted and co-authored by Quantify’s Joel Gunnarsson and Rosa Lauppe shows that supplementation with nutritional vitamin D is not effective in reducing parathyroid hormone (PTH) in patients with non-dialysis chronic kidney disease. However, it may be useful to prevent PTH levels from increasing. Check out the full findings by clicking on the link above!